Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05875701 |
|
Recruitment Status :
Completed
First Posted : May 25, 2023
Last Update Posted : March 5, 2024
|
Sponsor:
Novavax
Information provided by (Responsible Party):
Novavax
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 11, 2023 |
| Actual Study Completion Date : | November 11, 2023 |
| Certification/Extension First Submitted : | February 16, 2024 |